Veterinary drug company Phylaxia Pharma Rt sustained losses of Ft 126.3 million (€502,600) in 2005 after closing 2004 with losses of Ft 119.4 million, according to the company's flash report prepared in accordance with International Financial Reporting Standards (IFRS).. The consortium's operating losses rose to Ft 59.3 million in 2005, up from Ft 38.8 million in 2004. Phylaxia recorded a 321% gain in 2005 exports, though this increase was not enough to offset a 27% drop in domestic sales, resulting in a 15% overall decline in gross 2005 revenue to Ft 656.6 million. Phylaxia's 2005 export revenue of Ft 112.7 million constituted 17% of the company's total 2005 revenue, up from 3% in 2004. The company's domestic sales totaled Ft 543.9 million last year.